DE3580927D1 - Die antigenischen determinanten von hbxag. - Google Patents

Die antigenischen determinanten von hbxag.

Info

Publication number
DE3580927D1
DE3580927D1 DE8585301589T DE3580927T DE3580927D1 DE 3580927 D1 DE3580927 D1 DE 3580927D1 DE 8585301589 T DE8585301589 T DE 8585301589T DE 3580927 T DE3580927 T DE 3580927T DE 3580927 D1 DE3580927 D1 DE 3580927D1
Authority
DE
Germany
Prior art keywords
hbxag
antigenic determinants
assaying
hepatitis
cloning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585301589T
Other languages
English (en)
Inventor
Ann M Moriarty
Hannah Alexander
Richard A Lerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Application granted granted Critical
Publication of DE3580927D1 publication Critical patent/DE3580927D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Image Generation (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Editing Of Facsimile Originals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8585301589T 1984-03-08 1985-03-07 Die antigenischen determinanten von hbxag. Expired - Lifetime DE3580927D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58757084A 1984-03-08 1984-03-08
US06/648,142 US4777240A (en) 1984-03-08 1984-09-07 SV40 expression vector containing HBxAg as an expression marker

Publications (1)

Publication Number Publication Date
DE3580927D1 true DE3580927D1 (de) 1991-01-31

Family

ID=27080076

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585301589T Expired - Lifetime DE3580927D1 (de) 1984-03-08 1985-03-07 Die antigenischen determinanten von hbxag.

Country Status (13)

Country Link
US (3) US4777240A (de)
EP (1) EP0155147B1 (de)
JP (1) JPH0832721B2 (de)
AT (1) ATE59185T1 (de)
AU (1) AU594642B2 (de)
CA (1) CA1340732C (de)
DE (1) DE3580927D1 (de)
DK (1) DK175364B1 (de)
FI (1) FI86585C (de)
IL (1) IL74544A (de)
NO (1) NO172394C (de)
NZ (1) NZ211357A (de)
WO (1) WO1985003950A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
IE60285B1 (en) * 1985-12-18 1994-06-29 Microgenesys Inc Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
WO1989004964A1 (en) * 1987-11-16 1989-06-01 Fox Chase Cancer Center Determination of anti-pol as an early marker or viral hepatitis infection
JPH0260589A (ja) * 1988-08-26 1990-03-01 Natl Sci Council バクテリオファージｍ１３の遺伝子□ｄ２プロモーターを使用した大腸菌中での外来タンパクの高レベル産生
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
EP0491077A1 (de) * 1990-12-19 1992-06-24 Medeva Holdings B.V. Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome
US5872206A (en) * 1994-10-06 1999-02-16 The General Hospital Corporation Compositions and methods for interfering wtih hepatitis B virus infection
DE69820486D1 (de) * 1998-01-19 2004-01-22 Mogam Biotechnology Res Inst Y Liposomen, enthaltend peptidantigene, welche vom x-protein aus hepatitis b virus abstammen
AU2480799A (en) * 1998-01-29 1999-08-16 Thomas Jefferson University Molecular markers for diagnosing hepatocellular carcinoma
US6638903B2 (en) 2002-01-15 2003-10-28 Milliken & Company Non-staining red colorants and liquid fabric softener formulations comprising such non-staining colorants
US6593289B1 (en) 2002-01-15 2003-07-15 Milliken & Co. Liquid fabric softener formulations comprising hemicyanine red colorants
EP2675022B1 (de) 2004-07-13 2014-09-03 Panduit Corporation Kommunikationsverbinder mit flexibler Leiterplatte
US7357683B2 (en) 2005-07-15 2008-04-15 Panduit Corp. Communications connector with crimped contacts
WO2007110098A1 (en) * 2006-03-29 2007-10-04 Institut National De La Sante Et De La Recherche Medicale HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV
NZ586074A (en) * 2010-06-10 2013-07-26 Auckland Uniservices Ltd LCLRP peptides, constructs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
EP0155147A3 (en) 1985-11-06
JPS61502094A (ja) 1986-09-25
FI854395A0 (fi) 1985-11-07
ATE59185T1 (de) 1991-01-15
EP0155147B1 (de) 1990-12-19
CA1340732C (en) 1999-09-14
NZ211357A (en) 1988-08-30
NO854448L (no) 1986-01-06
FI854395A (fi) 1985-11-07
NO172394B (no) 1993-04-05
US4777240A (en) 1988-10-11
DK175364B1 (da) 2004-09-13
US5534405A (en) 1996-07-09
NO172394C (no) 1993-07-14
JPH0832721B2 (ja) 1996-03-29
WO1985003950A1 (en) 1985-09-12
AU594642B2 (en) 1990-03-15
IL74544A0 (en) 1985-06-30
US5183734A (en) 1993-02-02
FI86585B (fi) 1992-05-29
DK516585D0 (da) 1985-11-08
FI86585C (fi) 1992-09-10
DK516585A (da) 1985-11-08
EP0155147A2 (de) 1985-09-18
IL74544A (en) 1994-11-11
AU4067285A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
DE3580927D1 (de) Die antigenischen determinanten von hbxag.
NO165598C (no) Fremgangsmaate for ekspresjon av hepatitt b overflateantigen i cellekultur samt ekspresjonsvektor.
ES2056817T3 (es) Transformacion de trichoderma.
DE68915070D1 (de) Zellkultur-Reaktor.
DK0504177T3 (da) IL-11, et pattedyrcytokin
ZA864525B (en) Vector for expression of interferon-ypsilon in mammalian cells,method for using it and product obtained
IT7829543A0 (it) Metodo e composizioni per la determinazione diretta del ferro nel siero ematico.
EP0178891A3 (de) Human-humane Hybridzellinien die Antikörper gegen Antigendeterminanten von Krebszellen produzieren
DE3585049D1 (de) Monoklonale antikoerper.
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
ES8102357A1 (es) Procedimiento para la deteccion de anticuerpos antimitocon- driales o antinucleares
AU8436982A (en) Hybrid vectors and process for improving the amplification and expression of hybrid vectors by use of mitochondrial dna
DK302785A (da) Monoklonale antistoffer overfor humant interferon-gamma, hybridcellelinier, der frembringer disse antistoffer, antistoffernes anvendelse og fremgangsmaader til fremstilling deraf
Yu The implications of language, culture, social class, and cognitive style in higher cognitive processes: a cross-cultural, developmental study
DE69314633D1 (de) Methoden und Zusammensetzungen um die Sensitivität eine Zellegegen DNA-Zerstörende Agentien zu erhöhen
IT8583398A0 (it) Procedimento per la realizzazione di collezioni di campioni e macchina per l'esecuzione del procedimento.
BE904811A (fr) Anticorps monoclonaux.
IL63901A0 (en) Fungus strain and enzyme produced thereby
IT8125583A0 (it) Procedimento per l'estrazione di brodi di fermentazione nonfiltrati.
SU1264575A1 (ru) Способ иммобилизации клеток
ES8608882A1 (es) Vacuna contra la brucelosis
SU871552A1 (ru) Устройство для электрохимической обработки длинномерных изделий микронных толщин
UA11489A1 (uk) Спосіб визhачеhhя активhості тімозиhа
IT7823532V0 (it) Cordoncino portasigillo, particolarmente per capi d'abbigliamento e simili.
IT8022392V0 (it) Supporto per la trattenuta ordinata e per l'esposizione di oggetti in genere.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition